Abstract
Members of the organic anion transporting polypeptide (OATP) family are responsible for the cellular uptake of a broad range of endogenous compounds and xenobiotics in multiple tissues. This review focuses on OATP1B1 and -1B3, which are specifically expressed in the liver and considered to be of particular importance for hepatic drug elimination and drug pharmacokinetics. Recent literature has indicated that inhibition of these transporters may result in drug-drug interactions. Furthermore, genetic polymorphisms in the genes encoding OATP1B1 and -1B3 have been described that increase or decrease transport in vitro and in vivo. Alteration of transporter function by either of these mechanisms may contribute to interindividual variability in drug disposition and response. In this review an update of this rapidly emerging field is provided.
Original language | English |
---|---|
Pages (from-to) | 429-445 |
Number of pages | 17 |
Journal | Expert Opinion on Drug Metabolism and Toxicology |
Volume | 1 |
Issue number | 3 |
DOIs | |
State | Published - Oct 2005 |
Externally published | Yes |
Keywords
- OATP
- drug interaction
- hepatic transport
- pharmacogenetics